TrialInternational urology and nephrology2014

Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

Wen-Hua Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.